research funding database


Neuroimaging and CSF Biomarker Program (Alzheimer’s disease)

Share this post

Logo of scientifyRESEARCH and Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Neuroimaging and CSF Biomarker Program from the Alzheimer´s Drug Discovery Foundation provides funding to support the identification of biomarkers in Alzheimer´s disease. The grant is available to researchers worldwide, at both non-profit research institutions as well as for-profit organizations. This grant focuses on:

  • Developing novel PET ligands for clinical trials
  • Supporting novel CSF biomarkers
  • Validating innovative MRI approaches in larger cohorts
  • Developing novel measures of functional activity such as EEG

Applicants may apply for up to 600,000 USD (direct costs only) for 1 year with the potential for renewal. There are three assessment rounds per year. The next letter of intent is due May 13, 2024, and the full application is due on Jul 22, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
monthly funding newsletter

unsubscribe at any time